Respiratory Syncytial Virus Lower Respiratory Tract Disease
📧 Sign up to get email alerts when something new happens for Respiratory Syncytial Virus Lower Respiratory Tract Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-23Clinical Trial Results: A Study in India on the Immune Response and Safety of a Respiratory Syncytial Virus (RSV) Older Adults (OA) Vaccine When Given to Older Adults 60 Years of Age and Above and Adults 50-59 Years of Age at Increased Risk (AIR) of Respiratory Syncytial Virus Lower Respiratory Tract Disease (RSV-LRTD) [Phase 3]
Phase 3 trial results evaluating safety and immune response of an RSV vaccine in older adults (60+) and high-risk adults (50-59) with RSV-LR…